Concepedia

Yuka Nogami

YN

Statistics

Publications

7

Citations

198

H-Index

7

Active since

2017

Affiliations

Kawasaki Medical School(Current)

Kawasaki Hospital

Yuka Nogami is an author at Kawasaki Medical School specializing in endocrinology, diabetes mellitus, and pharmacology.

Publications per year

2017–2024

7

Publications

7

Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in <i>db/db</i> mice: The earlier and longer, the better

Tomohiko Kimura, Atsushi Obata, Masashi Shimoda et al. · Diabetes Obesity and Metabolism · 2018 · 52 citations

, , +17

Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules

Junpei Sanada, Atsushi Obata, Yoshiro Fushimi et al. · Scientific Reports · 2022 · 44 citations · Full text

, , +17

Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure

Tomohiko Kimura, Atsushi Obata, Masashi Shimoda et al. · Diabetes & Metabolism · 2018 · 36 citations

, , +17

Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic <i>db/db</i> mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor

Tomohiko Kimura, Atsushi Obata, Masashi Shimoda et al. · Diabetes and Vascular Disease Research · 2017 · 23 citations · Full text

, , +17

Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice

Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan et al. · Diabetes Obesity and Metabolism · 2024 · 16 citations

, , +17

1–5 of 7